WuXi debuts first vaccine CDMO site in China, where it plans to employ more than 500 fkansteiner Tue, 09/26/2023 – 15:06 More: WuXi debuts first vaccine CDMO site in China, where it plans to employ more than 500 Source: fierce
read moreMerck KGaA’s MilliporeSigma pumps €28M into 2 new mRNA production plants fkansteiner Tue, 09/26/2023 – 11:59 More: Merck KGaA's MilliporeSigma pumps €28M into 2 new mRNA production plants Source: fierce
read moreAfter 2 FDA rejections and restructuring drive, Intercept sells itself to Italy’s Alfasigma zbecker Tue, 09/26/2023 – 10:43 More: After 2 FDA rejections and restructuring drive, Intercept sells itself to Italy's Alfasigma Source: fierce
read moreGilead Sciences, after trial win, moves ahead with $247M settlement in HIV antitrust case esagonowsky Tue, 09/26/2023 – 10:39 More: Gilead Sciences, after trial win, moves ahead with 7M settlement in HIV antitrust case Source: fierce
read moreUK puts CSL Seqirus on standby for flu pandemic preparedness, with vaccines to be produced in Liverpool kdunleavy Tue, 09/26/2023 – 10:12 More: UK puts CSL Seqirus on standby for flu pandemic preparedness, with vaccines to be produced in Liverpool
read moreEpiSwitch is designed for men with prostate cancer risk in the UK and is 94% accurate More: Oxford Biodynamics launches prostate screening test Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals